Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Rabin, KR"'
Autor:
Baughn, LB, Biegel, JA, South, ST, Smolarek, T, Volkert, S, Carroll, A, Heerema, NA, Rabin, KR, Zweidler-McKay, PA, Loh, M, Hirsch, B
It is well documented that among subgroups of B-cell acute lymphoblastic leukemia (B-ALL), the genetic profile of the leukemic blasts has significant impact on prognosis and stratification for therapy. Recent studies have documented the power of micr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::511c16d655f291cf1d6741ada955b594
https://europepmc.org/articles/PMC5361577/
https://europepmc.org/articles/PMC5361577/
Publikováno v:
Flavour and Fragrance Journal. 21:239-240
The leaf essential oil of Callistemon lanceolatus D.C., obtained by hydrodistillation from matured leaves grown at Jorhat, Assam, in the north-eastern region of India, were analysed by GC and GC–MS. A total of 16 compounds were identified and 1,8 c
Autor:
Rabin KR (AUTHOR)
Publikováno v:
New England Journal of Medicine. 4/12/2012, Vol. 366 Issue 15, p1445-1446. 2p.
Publikováno v:
Flavour & Fragrance Journal; Mar2006, Vol. 21 Issue 2, p239-240, 2p
Autor:
Andrea Pession, Karen R. Rabin, Debra J. Morrison, Nyla A. Heerema, Deepa Bhojwani, Gregory Condos, Michael G. Loudin, Giuseppe Basso, Sivashankarappa Gurusiddappa, Hon-Chiu Eastwood Leung, Meenakshi Devidas, Sharon E. Plon, Julia Meyer, Stephen P. Hunger, Jinhua Wang, William L. Carroll, Anna Tsimelzon, Andrew J. Carroll
Publikováno v:
Leukemia. 25:1555-1563
Patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) have distinct clinical and biological features. Whereas most DS-ALL cases lack the sentinel cytogenetic lesions that guide risk assignment in childhood ALL, JAK2 mutations and CR
Autor:
Andrea Pession, Karen R. Rabin, Giuseppe Basso, Meenakshi Devidas, Shai Izraeli, Cassia L. Rye, Amos Gaikwad, Nyla A. Heerema, Sharon E. Plon, Andrew J. Carroll
Publikováno v:
British Journal of Haematology. 144:930-932
Recurrent, prognostically significant chromosomal abnormalities occur in approximately 75% of paediatric acute lymphoblastic leukaemia (ALL), but only infrequently in children with Down syndrome (DS) and ALL. Recently, novel somatic activating mutati
Autor:
Richard T. Williams, Julia Meyer, Nyla A. Heerema, Charles G. Mullighan, Stephen P. Hunger, Jing Ma, William L. Carroll, Cheryl L. Willman, Fady M. Mikhail, Wei Liu, Giuseppe Basso, Letha A. Phillips, Jinjun Cheng, Andrew J. Carroll, Jinghui Zhang, Richard C. Harvey, Andrea Pession, Karen R. Rabin, Susana C. Raimondi, Elaine Coustan-Smith, Michael G. Loudin, J. Racquel Collins-Underwood, James R. Downing, Ching-Hon Pui
Publikováno v:
Nature genetics. 41(11)
Aneuploidy and translocations are hallmarks of B-progenitor acute lymphoblastic leukemia (ALL), but many patients lack a recurring chromosomal alteration. Here we report a recurring interstitial deletion of the pseudoautosomal region 1 of chromosomes
Autor:
Chang TC; Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN., Chen W; Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN.; Division of Computational Biology, Mayo Clinic, Rochester, MN., Qu C; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN., Cheng Z; Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN., Hedges D; Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN.; Deceased., Elsayed A; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN., Pounds SB; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN., Shago M; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Rabin KR; Department of Pediatrics, Baylor College of Medicine, Houston, TX., Raetz EA; Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Hospital, New York, NY., Devidas M; Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN., Cheng C; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN., Angiolillo A; Children's National Medical Center, Washington, DC., Baviskar P; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN., Borowitz M; Department of Pathology, Johns Hopkins University, Baltimore, MD., Burke MJ; Division of Pediatric Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI., Carroll A; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL., Carroll WL; Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Hospital, New York, NY., Chen IM; Department of Pathology, University of New Mexico, Albuquerque, NM., Harvey R; Department of Pathology, University of New Mexico, Albuquerque, NM., Heerema N; The Ohio State University, Columbus, OH., Iacobucci I; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN., Wang JR; Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC., Jeha S; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN., Larsen E; Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME., Mattano L; HARP Pharma Consulting, Mystic, CT., Maloney K; Department of Pediatrics and Children's Hospital Colorado, University of Colorado, Aurora, CO., Pui CH; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN., Ramirez NC; Departments of Pathology and Pediatrics, Institute for Genomic Medicine and Biopathology Center, Nationwide Children's Hospital, Ohio State University, Columbus, OH., Salzer W; Uniformed Services University, School of Medicine, Bethesda, MD., Willman C; Department of Laboratory Medicine and Pathology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN., Winick N; Department of Pediatric Hematology Oncology and Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Wood B; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA., Hunger SP; Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Wu G; Center for Applied Bioinformatics, St Jude Children's Research Hospital, Memphis, TN.; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN., Mullighan CG; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN., Loh ML; Department of Pediatrics and the Ben Towne Center for Childhood Cancer Research, Seattle Children's Hospital, University of Washington, Seattle, WA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 10; Vol. 42 (29), pp. 3491-3503. Date of Electronic Publication: 2024 Aug 09.
Autor:
Belsky JA; Department of Pediatrics, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Chavana A; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA., Banerjee A; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA., Zobeck M; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, Texas, USA., Schafer ES; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, Texas, USA., Rabin KR; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, Texas, USA., Gramatges M; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, Texas, USA., Sim A; College of Pharmacy, University of Texas, Houston, Texas, USA., Leisinger A; Department of Pediatrics, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Reddy T; Department of Pediatrics, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Parod MJ; Department of Pediatrics, Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Lupo P; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, Texas, USA., Scheurer M; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, Texas, USA., Brown AL; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, Texas, USA., Bernhardt MB; Department of Pharmacy and Pharmaceutical Science, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2025 Jan; Vol. 72 (1), pp. e31377. Date of Electronic Publication: 2024 Oct 10.
Autor:
Feldman ER; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322., Li Y; Center for Genetic Epidemiology, Keck School of Medicine of University of Southern California, Los Angeles, CA., Cutler DJ; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322., Rosser TC; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322., Wechsler SB; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322., Sanclemente L; Baylor College of Medicine, Houston, TX., Rachubinski AL; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO., Elliott N; Department of Paediatrics and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford, UK., Vyas P; Department of Paediatrics and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford, UK., Roberts I; Department of Paediatrics and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford, UK., Rabin KR; Baylor College of Medicine, Houston, TX., Wagner M; Cincinnati Children's Hospital Medical Center, Cincinnati, OH., Gelb BD; Icahn School of Medicine at Mount Sinai, New York, NY., Espinosa JM; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO., Lupo PJ; Baylor College of Medicine, Houston, TX., de Smith AJ; Center for Genetic Epidemiology, Keck School of Medicine of University of Southern California, Los Angeles, CA., Sherman SL; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322., Leslie EJ; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Sep 06. Date of Electronic Publication: 2024 Sep 06.